Chrystal Louis

Chrystal Louis

Chief Tech/Sci/R&D Officer at TSCAN THERAPEUTICS, INC.

Net worth: - $ as of 30/05/2026

50 year
Health Technology
Consumer Services

Profile

Chrystal U.
Louis
is currently Chief Medical Officer at TScan Therapeutics, Inc. since 2024.
Formerly, Dr. Louis was Senior VP-Hematology Clinical Development at Zentalis Pharmaceuticals, Inc. from 2022 to 2024, Vice President & Head-Medical Affairs at CRISPR Therapeutics, Inc. from 2020 to 2022, and Executive Director-Myeloid Diseases at Celgene Corp.
from 2018 to 2019.
Education includes graduate and doctorate degrees from Tulane University School of Medicine and an undergraduate degree from Southwestern University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 0 ( -.--% ) - $ 30/05/2026

Chrystal Louis active positions

CompaniesPositionStart
TSCAN THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 07/04/2024

Former positions of Chrystal Louis

CompaniesPositionEnd
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 29/02/2024
Corporate Officer/Principal 31/10/2022
CELGENE Corporate Officer/Principal 31/12/2018
See the detail of Chrystal Louis's experience

Training of Chrystal Louis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

20

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Chrystal Louis
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!